59
Views
8
CrossRef citations to date
0
Altmetric
Editorial

Statin therapy and new-onset diabetes: an attempt at recommendations

&
Pages 213-216 | Published online: 10 Jan 2014
 

Financial & competing interests disclosure

M Banach has given talks, attended conferences and participated in trials and advisory boards sponsored by AstraZeneca, Amgen, MSD, KRKA, Polfarmex, Synageva and Abbott. DP Mikhailidis has given talks, attended conferences and participated in trials and advisory boards sponsored by MSD, Genzyme and Abbott. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.